These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate. Soroka D, Ourghanlian C, Compain F, Fichini M, Dubée V, Mainardi JL, Hugonnet JE, Arthur M. J Antimicrob Chemother; 2017 Apr 01; 72(4):1081-1088. PubMed ID: 28039278 [Abstract] [Full Text] [Related]
3. Crystal Structure of Phosphoserine BlaC from Mycobacterium tuberculosis Inactivated by Bis(Benzoyl) Phosphate. Moural TW, White DS, Choy CJ, Kang C, Berkman CE. Int J Mol Sci; 2019 Jul 02; 20(13):. PubMed ID: 31269656 [Abstract] [Full Text] [Related]
5. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates. Totir MA, Padayatti PS, Helfand MS, Carey MP, Bonomo RA, Carey PR, van den Akker F. Biochemistry; 2006 Oct 03; 45(39):11895-904. PubMed ID: 17002290 [Abstract] [Full Text] [Related]
6. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations. Kurz SG, Wolff KA, Hazra S, Bethel CR, Hujer AM, Smith KM, Xu Y, Tremblay LW, Blanchard JS, Nguyen L, Bonomo RA. Antimicrob Agents Chemother; 2013 Dec 03; 57(12):6085-96. PubMed ID: 24060876 [Abstract] [Full Text] [Related]
7. Structural Insights into the Inhibition of the Extended-Spectrum β-Lactamase PER-2 by Avibactam. Ruggiero M, Papp-Wallace KM, Brunetti F, Barnes MD, Bonomo RA, Gutkind G, Klinke S, Power P. Antimicrob Agents Chemother; 2019 Sep 03; 63(9):. PubMed ID: 31235626 [Abstract] [Full Text] [Related]
13. Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis. Egesborg P, Carlettini H, Volpato JP, Doucet N. Protein Sci; 2015 Apr 03; 24(4):534-44. PubMed ID: 25492589 [Abstract] [Full Text] [Related]
14. β-Lactamase of Mycobacterium tuberculosis Shows Dynamics in the Active Site That Increase upon Inhibitor Binding. Elings W, Gaur A, Blok AJ, Timmer M, van Ingen H, Ubbink M. Antimicrob Agents Chemother; 2020 Feb 21; 64(3):. PubMed ID: 31871087 [Abstract] [Full Text] [Related]
15. The G132S Mutation Enhances the Resistance of Mycobacterium tuberculosis β-Lactamase against Sulbactam. van Alen I, Chikunova A, Safeer AA, Ahmad MUD, Perrakis A, Ubbink M. Biochemistry; 2021 Jul 20; 60(28):2236-2245. PubMed ID: 34250791 [Abstract] [Full Text] [Related]
16. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates. Zhang D, Wang Y, Lu J, Pang Y. Antimicrob Agents Chemother; 2016 Jan 20; 60(1):393-9. PubMed ID: 26525785 [Abstract] [Full Text] [Related]
17. Bis(benzoyl) phosphate inactivators of beta-lactamase C from Mtb. White DS, Choy CJ, Moural TW, Martin SE, Wang J, Gargaro S, Kang C, Berkman CE. Bioorg Med Chem Lett; 2019 Aug 15; 29(16):2116-2118. PubMed ID: 31281019 [Abstract] [Full Text] [Related]
18. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam. Papp-Wallace KM, Winkler ML, Taracila MA, Bonomo RA. Antimicrob Agents Chemother; 2015 Jul 15; 59(7):3710-7. PubMed ID: 25666153 [Abstract] [Full Text] [Related]
19. Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition. Elings W, Tassoni R, van der Schoot SA, Luu W, Kynast JP, Dai L, Blok AJ, Timmer M, Florea BI, Pannu NS, Ubbink M. Biochemistry; 2017 Nov 28; 56(47):6257-6267. PubMed ID: 29087696 [Abstract] [Full Text] [Related]
20. Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence. Kalp M, Totir MA, Buynak JD, Carey PR. J Am Chem Soc; 2009 Feb 18; 131(6):2338-47. PubMed ID: 19161282 [Abstract] [Full Text] [Related] Page: [Next] [New Search]